Skip to Content

Mogamulizumab

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

1159266-37-1

Chemical Formula

C6520-H10072-N1736-O2020-S42

Therapeutic Categories

Antineoplastic agent

Monoclonal antibody

Chemical Name

Immunoglobulin G1-kappa, anti-[Homo sapiensCCR4 (chemokine (C-C motif) receptor 4, CC chemokine receptor 4, CCR-4, CKR4, k5-5, CD194)], humanized monoclonal antibody;gamma1 heavy chain (1-449) [humanized VH (Homo sapiensIGHV3-21*01 (83.70%) -(IGHD)-IGHJ4* (WHO )

Foreign Names

  • Mogamulizumabum (Latin)
  • Mogamulizumab (German)
  • Mogamulizumab (French)
  • Mogamulizumab (Spanish)

Generic Names

Brand Name

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide